GLOB:NYSEGlobant S.A. Analysis

Globant trades at $37.49, well below its DCF fair value of $76.02, implying an upside of roughly 64%. The stock sits beneath its 20‑day SMA (39.49) and 50‑day SMA (41.75), while the 200‑day SMA remains at 54.83, indicating a bearish technical backdrop reinforced by a negative MACD histogram and a neutral RSI of 43. Volume is on a decreasing trend, and volatility is elevated at over 70%**30‑day**, reflecting heightened price swings. Fundamentally, the company shows a modest PE of 15.2 versus an industry average of 36.8, a low forward PE of 5.68, and a price‑to‑book below 1, all pointing to significant undervaluation. Recent Q1 2026 results beat guidance, driven by strong AI Pods growth and a newly announced share‑repurchase program, which supports a medium‑term rebound. However, the stock faces lingering legal exposure from a securities class‑action covering the 2024‑2025 period and lingering concerns over its troubled Latin American expansion, adding to geographic and regulatory risk. The balance of these factors suggests a near‑term cautionary stance, but a compelling upside thesis for investors with a longer horizon.